BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 27040699)

  • 1. Gene mutations in chronic lymphocytic leukemia.
    Amin NA; Malek SN
    Semin Oncol; 2016 Apr; 43(2):215-21. PubMed ID: 27040699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Quantitative Analysis of Subclonal and Clonal Gene Mutations before and after Therapy in Chronic Lymphocytic Leukemia.
    Amin NA; Seymour E; Saiya-Cork K; Parkin B; Shedden K; Malek SN
    Clin Cancer Res; 2016 Sep; 22(17):4525-35. PubMed ID: 27060156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal evolution in chronic lymphocytic leukemia: impact of subclonality on disease progression.
    Sutton LA; Rosenquist R
    Expert Rev Hematol; 2015 Feb; 8(1):71-8. PubMed ID: 25345442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complex interplay between cell-intrinsic and cell-extrinsic factors driving the evolution of chronic lymphocytic leukemia.
    Sutton LA; Rosenquist R
    Semin Cancer Biol; 2015 Oct; 34():22-35. PubMed ID: 25963298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel diagnostic biosensor for distinguishing immunoglobulin mutated and unmutated types of chronic lymphocytic leukemia.
    Ensafi AA; Amini M; Rezaei B; Talebi M
    Biosens Bioelectron; 2016 Mar; 77():409-15. PubMed ID: 26436328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting Prognosis in Chronic Lymphocytic Leukemia in the Contemporary Era.
    Nabhan C; Raca G; Wang YL
    JAMA Oncol; 2015 Oct; 1(7):965-74. PubMed ID: 26181643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of NOTCH1, MYD88, and SF3B1 mutations in Polish patients with chronic lymphocytic leukemia.
    Putowski M; Podgórniak M; Piróg M; Knap J; Zaleska J; Purkot J; Zawiślak J; Zakrzewska E; Karczmarczyk A; Własiuk P; Subocz E; Giannopoulos K
    Pol Arch Intern Med; 2017 Apr; 127(4):238-244. PubMed ID: 28424451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOTCH1 mutations in CLL associated with trisomy 12.
    Balatti V; Bottoni A; Palamarchuk A; Alder H; Rassenti LZ; Kipps TJ; Pekarsky Y; Croce CM
    Blood; 2012 Jan; 119(2):329-31. PubMed ID: 22086416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia.
    Rassenti LZ; Huynh L; Toy TL; Chen L; Keating MJ; Gribben JG; Neuberg DS; Flinn IW; Rai KR; Byrd JC; Kay NE; Greaves A; Weiss A; Kipps TJ
    N Engl J Med; 2004 Aug; 351(9):893-901. PubMed ID: 15329427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Analysis of Disease-Related Genes in Chronic Lymphocytic Leukemia by Multiplex PCR-Based Next Generation Sequencing.
    Vollbrecht C; Mairinger FD; Koitzsch U; Peifer M; Koenig K; Heukamp LC; Crispatzu G; Wilden L; Kreuzer KA; Hallek M; Odenthal M; Herling CD; Buettner R
    PLoS One; 2015; 10(6):e0129544. PubMed ID: 26053404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic data integration in chronic lymphocytic leukemia.
    Fernández-Martínez JL; deAndrés-Galiana EJ; Sonis ST
    J Gene Med; 2017 Jan; 19(1-2):. PubMed ID: 27928896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted resequencing for analysis of clonal composition of recurrent gene mutations in chronic lymphocytic leukaemia.
    Jethwa A; Hüllein J; Stolz T; Blume C; Sellner L; Jauch A; Sill M; Kater AP; te Raa GD; Geisler C; van Oers M; Dietrich S; Dreger P; Ho AD; Paruzynski A; Schmidt M; von Kalle C; Glimm H; Zenz T
    Br J Haematol; 2013 Nov; 163(4):496-500. PubMed ID: 24032483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl-6 mutation status provides clinically valuable information in early-stage B-cell chronic lymphocytic leukemia.
    Sarsotti E; Marugan I; Benet I; Terol MJ; Sanchez-Izquierdo D; Tormo M; Rubio-Moscardo F; Martinez-Climent JA; García-Conde J
    Leukemia; 2004 Apr; 18(4):743-6. PubMed ID: 14961033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examination of clonal evolution in chronic lymphocytic leukemia.
    Koczkodaj D; Popek-Marciniec S; Zmorzyński S; Wąsik-Szczepanek E; Filip AA
    Med Oncol; 2019 Aug; 36(9):79. PubMed ID: 31375939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel prognostic molecular factors: a quantum leap in the field of chronic lymphocytic leukemia.
    Zakrzewska E; Pirog M; Purkot J; Giannopoulos K
    Folia Histochem Cytobiol; 2017; 55(3):95-106. PubMed ID: 28994094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
    Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
    Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic signature and clonality pattern of recurrently mutated genes in inactive chronic lymphocytic leukemia.
    Hurtado AM; Chen-Liang TH; Przychodzen B; Hamedi C; Muñoz-Ballester J; Dienes B; García-Malo MD; Antón AI; de Arriba F; Teruel-Montoya R; Ortuño FJ; Vicente V; Maciejewski JP; Jerez A
    Blood Cancer J; 2015 Aug; 5(8):e342. PubMed ID: 26314984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of TP53 mutations with the AmpliChip p53 research test in chronic lymphocytic leukemia: correlation with clinical outcome and gene expression profiling.
    Chiaretti S; Tavolaro S; Marinelli M; Messina M; Del Giudice I; Mauro FR; Santangelo S; Piciocchi A; Peragine N; Truong S; Patten N; Ghia EM; Torrente I; De Propris MS; Nanni M; Lawrence J; Guarini A; Foà R
    Genes Chromosomes Cancer; 2011 Apr; 50(4):263-74. PubMed ID: 21319261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness.
    Rossi D; Cerri M; Deambrogi C; Sozzi E; Cresta S; Rasi S; De Paoli L; Spina V; Gattei V; Capello D; Forconi F; Lauria F; Gaidano G
    Clin Cancer Res; 2009 Feb; 15(3):995-1004. PubMed ID: 19188171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Landscape of NOTCH1 mutations and co-occurring biomarker alterations in chronic lymphocytic leukemia.
    Jelloul FZ; Yang R; Garces S; Kanagal-Shamanna R; Ok CY; Loghavi S; Routbort MJ; Zuo Z; Yin CC; Floyd K; Bassett RL; Wierda W; Jain N; Thompson P; Luthra R; Medeiros LJ; Patel KP
    Leuk Res; 2022 May; 116():106827. PubMed ID: 35430388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.